The Influence of Daily Strawberry Intake on Vascular Health in Elderly Men

NCT ID: NCT04763499

Last Updated: 2023-05-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

4 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall objective of this proposed trial is to examine the vascular protective effects provided by the daily consumption of 39g of freeze dried strawberry powder (FDSP) for four weeks. The study population will be older men (60-80 years of age).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The proposed project will determine the influence of short-term FDSP intake on microvascular function in older men (60-80 years of age). The Framingham reactive hyperemia index (fRHI) will be used as a measure of microvascular function, and will be measured using peripheral arterial tonometry (PAT; EndoPAT200). Secondary outcomes will assess circulating levels of nitrate and nitrite, insulin-like growth factor (IGF), inflammatory cytokines, NADPH oxidase, platelet aggregation, plasma lipids and blood pressure. This suite of markers will provide insight on physiological outcomes and risk factors associated with CVD development, and the metabolic and signaling pathways that influence them. To accomplish the above, after a 4 week run in period of no powder intake, twenty men (60-80 years of age) will be randomly assigned to consume 39 g of FDSP or a control powder for four weeks in a randomized, double-blind, controlled crossover study. This study design will compare the short-term (four week) response of FDSP intake to an isocaloric control powder that provides no polyphenols, as well as to their habitual diet where no powder was consumed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vascular Dilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

A randomized, double-blind, crossover dietary intervention trial.
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators
both the control and freeze dried strawberry powders are package with only a code as the identifier

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Freeze dried strawberry powder

39g of freeze dried strawberry powder, which represents three daily servings of strawberries.

The powder will be mixed in one cup of water.

Group Type EXPERIMENTAL

freeze dried strawberry powder

Intervention Type OTHER

approximately 24 strawberries that have been freeze dried into a powder

control powder

39 g of a powder that matches the sugar and caloric content of the experimental powder. The powder will be mixed in one cup of water.

Group Type PLACEBO_COMPARATOR

freeze dried strawberry powder

Intervention Type OTHER

approximately 24 strawberries that have been freeze dried into a powder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

freeze dried strawberry powder

approximately 24 strawberries that have been freeze dried into a powder

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is willing and able to comply with the study protocols.
* Subject is willing to participate in all study procedures
* BMI 25.0 - 35 kg/m2

Exclusion Criteria

* BMI ≥ 35 kg/m2
* Visit 1 Reactive Hyperemia Index (RHI; EndoPAT 2000) ≥ 2.8
* Dislike or allergy strawberries
* Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
* Prescription medications other than on a 6 month self-reported stable dose of medications for lipid lowering and/or hypertension.
* Vegan, Vegetarians, food faddists or those consuming a non-traditional diet
* Fruit consumption ≥ 3 cups/day
* Regular consumption of strawberries (2-3 servings/week)
* Vegetable consumption ≥ 4 cups/day
* Coffee/tea ≥ 3 cups/day
* Dark chocolate ≥ 3 oz/day
* Self-reported restriction of physical activity due to a chronic health condition
* Self-reported chronic/routine high intensity exercise
* Self-reported diabetes
* Blood pressure ≥ 140/90 mm Hg
* Self-reported renal or liver disease
* Self-reported heart disease, which includes cardiovascular events and stroke
* Peripheral artery disease Raynaud's syndrome or disease
* Inability to properly place or wear the PAT probes or abnormal measurements on pre- screening PAT
* Abnormal Metabolic or CBC panels (laboratory values outside the reference range) if determined to be clinically significant by the study physician.
* Self-reported cancer within past 5 years
* Self-reported malabsorption
* Supplement use other than a general formula of vitamins and minerals that meet the RDA
* Not willing to stop any supplement use, including herbal, plant or botanical, fish oil, oil supplements a month prior to study enrollment.
* Indications of substance or alcohol abuse within the last 3 years
* Cannabis use
* Current enrollee in a clinical research study.
Minimum Eligible Age

60 Years

Maximum Eligible Age

80 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carl L Keen, PhD

Role: PRINCIPAL_INVESTIGATOR

Professor of Nutrition and Internal Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California, Davis; Department of Nutrition

Davis, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1567320

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Understanding Dose Related Effects of Strawberry
NCT06173765 ACTIVE_NOT_RECRUITING NA